Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co
17/11/2024 22:53
Nov 18 (Reuters) - Resonance Health Ltd RHT.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON EXECUTION OF
CONTRACT FOR SERVICES FOR CLINICAL TRIAL BY A PHARMACEUTICAL CO
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co